Day : June 25, 2018

Current News Market Watch Uncategorized

FDA Approves GW Pharma’s CBD Derived Epidiolex to Treat Epilepsy

Editor
The United States Food & Drugs Administration (FDA) has officially approved GW Pharmaceuticals’ (NASDAQ: GWPH) Cannabidiol (CBD) derived medication called Epidiolex. The newly approved drug is a oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The new CBD derived pharmaceutical will be...
Current News Market Watch Uncategorized

Tilray Inc. Files For Proposed IPO on Nasdaq

Editor
Tilray Inc., A Canadian cannabis cultivator, processor, and distributor, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) on the Nasdaq Global Select Market. The ticker symbol “TLRY” will be used, and will offer shares of its Class 2...